Several classification systems, all based on disease severity, have been created to guide treatment decisions in psoriasis. In the most widely used system, disease severity is scored according to ...

Patients suffer numerous psychosocial difficulties commensurate with the extent of their physical disfigurement. Consequently, psoriasis can be physically and emotionally debilitating and can ...

Psoriasis is a chronic skin disorder characterized by epidermal hyperproliferation and dermal inflammation that vary in severity, from minor, localized patches to complete body coverage.

Trials of new agents—such as alefacept, efalizumab, and tumour necrosis factor α (TNFα) inhibitors such as etanercept and infliximab—have demonstrated that patients’ quality of life clearly improves ...

Objectives To assess the efficacy and safety of abatacept, a selective T-cell costimulation modulator, in a phase III study in psoriatic arthritis (PsA). Methods This study randomised patients (1:1) ...